For the year ending 2025-12-31, RXST has $311,814K in assets. $36,131K in debts. $19,949K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 19,949 | |||
| Short-term investments | 208,179 | |||
| Accounts receivable | 23,383 | |||
| Inventories, net | 31,559 | |||
| Prepaid and other current assets | 4,389 | |||
| Total current assets | 287,459 | |||
| Total property and equipment | 39,624 | |||
| Less accumulated depreciation and amortization | 26,568 | |||
| Property and equipment, net | 13,056 | |||
| Operating leases right-of-use assets | 9,959 | |||
| Restricted cash | 750 | |||
| Other assets | 590 | |||
| Total assets | 311,814 | |||
| Accounts payable | 5,296 | |||
| Accrued expenses and other current liabilities | 19,795 | |||
| Lease liabilities | 1,162 | |||
| Total current liabilities | 26,253 | |||
| Long-term lease liabilities | 9,878 | |||
| Other long-term liabilities | 0 | |||
| Total liabilities | 36,131 | |||
| Common stock, 0.001 par value, 900,000,000 shares authorized, 41,242,005 shares issued and outstanding as of december 31, 2025 and 40,428,220 shares issued and outstanding as of december 31, 2024 | 41 | |||
| Additional paid-in capital | 936,628 | |||
| Accumulated other comprehensive loss | 53 | |||
| Accumulated deficit | -661,039 | |||
| Total stockholders' equity | 275,683 | |||
| Total liabilities and stockholders' equity | 311,814 | |||
RxSight, Inc. (RXST)
RxSight, Inc. (RXST)